Jing Zhuang | Oncology | Best Researcher Award

Posted on by sciencefather

Ms. Jing Zhuang | Oncology | Best Researcher Award

Huzhou Central Hospital | China

Zhuang Jing is a dedicated head nurse at Huzhou Central Hospital with a master’s degree in nursing. She plays a pivotal role in the Zhejiang-France United Laboratory of Integrated Traditional Chinese and Modern Medicine in Colorectal Cancer and the Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou. Her research focuses on digestive tumors and intestinal microecology, contributing significantly to clinical advancements and patient care.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

🎗️ Zhuang Jing has demonstrated a remarkable commitment to advancing research in colorectal cancer with a focus on intestinal microecology. As a leading member of the Zhejiang-France United Laboratory and the Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer, her involvement in 36 research projects and authorship of over 50 SCI-indexed publications reflect her substantial contribution to the field. Additionally, her work’s impact is evidenced by an H-index of 13 and two patents, showcasing both innovation and scientific rigor. These achievements align well with the criteria for a “Best Researcher Award.”

Education 🎓

Zhuang Jing holds a master’s degree in nursing, equipping her with advanced knowledge and skills to excel in clinical and research settings. Her academic background has provided a solid foundation for her pursuits in oncology and digestive cancer research.

Experience 💼

As the head nurse at Huzhou Central Hospital, Zhuang Jing has extensive experience in patient care, research coordination, and multidisciplinary collaboration. She is a key member of international research initiatives, particularly in colorectal cancer studies, where she integrates traditional Chinese and modern medical practices.

Research Interests On Oncology🔬

Her primary research interests lie in digestive tumors and intestinal microecology. Zhuang focuses on exploring the relationship between gut health and cancer, aiming to develop innovative therapeutic strategies for colorectal cancer.

Awards 🏆

Zhuang Jing’s contributions to oncology and nursing have earned her recognition in the medical community. She is currently nominated for the Best Researcher Award at the Forensic Scientist Awards, acknowledging her outstanding achievements in digestive cancer research.

Publications 📚

  1. Gut microbial subtypes and clinicopathological value for colorectal cancer

    • Authors: Shuwen Han, Jing Zhuang, Yifei Song, Xinyue Wu, Xiaojian Yu, Ye Tao, Jian Chu, Zhanbo Qu, Yinhang Wu, Shugao Han et al.

    • Year: 2024

  2. Trace elements in pancreatic cancer

    • Authors: Yao Yanjun, Zhuang Jing, Song Yifei, Gu Gangzhao, Yan Chenxin, Wei Qiang, Yan Qiang, Han Shuwen

    • Year: 2024

  3. Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T‐cell costimulator as a crucial immune checkpoint molecule

    • Authors: Jian Chu, Yinghang Wu, Zhanbo Qu, Jing Zhuang, Jiang Liu, Shugao Han, Wei Wu, Shuwen Han

    • Year: 2024

  4. Aging characteristics of colorectal cancer based on gut microbiota

    • Authors: Yinhang Wu, Jing Zhuang, Qi Zhang, Xingming Zhao, Gong Chen, Shugao Han, Boyang Hu, Wei Wu, Shuwen Han

    • Year: 2023

  5. Developing a Diagnostic Model to Predict the Risk of Asthma Based on Ten Macrophage‐Related Gene Signatures

    • Authors: Xiaoshun Ai, Hong Shen, Yangyanqiu Wang, Jing Zhuang, Yani Zhou, Furong Niu, Qing Zhou, Si Qin

    • Year: 2022

  6. Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer

    • Authors: Jing Zhuang

    • Year: 2020

  7. Analysis of T lymphocyte-related biomarkers in pancreatic cancer

    • Authors: Jing Zhuang

    • Year: 2020

  8. Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites

    • Authors: Jing Zhuang

    • Year: 2020

  9. Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression

    • Authors: Jing Zhuang

    • Year: 2020

  10. Biological roles of piRNAs in colorectal cancer

  • Authors: Jing Zhuang

  • Year: 2020

  1. Predicting biomarkers from classifier for liver metastasis of colorectal adenocarcinomas using machine learning models

  • Authors: Jing Zhuang

  • Year: 2020

  1. Biological significance of piRNA in liver cancer: a review

  • Authors: Jing Zhuang

  • Year: 2020

Conclusion 🔖

Zhuang Jing’s commitment to advancing colorectal cancer research through the lens of intestinal microecology has made her a prominent figure in the field. Her extensive publication record, clinical expertise, and dedication to improving patient outcomes exemplify her remarkable contributions to healthcare and medical research.

Yuchun Wei | Oncology | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Yuchun Wei | Oncology | Best Researcher Award

Shandong Cancer Hospital | China

Dr. Yuchun Wei is a distinguished oncology researcher and radiotherapy physician at Shandong Cancer Hospital, China. Her work focuses on developing new imaging biomarkers for cancer detection, biological characterization, staging, and individualized therapy planning. With a deep commitment to advancing medical imaging, Dr. Wei’s research explores innovative imaging methods to improve cancer diagnostics and treatment.

Professional profile👤

Scopus

Strengths for the Awards✨

  • 🌟 Exceptional Research Contributions: Dr. Wei has an impressive record of high-impact publications in prestigious journals like Radiology (IF=19.7), J Nucl Med (IF=11.082), and Eur J Nucl Med Mol Imaging (IF=10.057), reflecting the quality and significance of her work.

  • 🔬 Pioneering Work in Imaging Biomarkers: Her research focuses on developing new imaging methods for cancer detection, prognosis, and treatment monitoring, demonstrating innovation and addressing critical needs in oncology.

  • 📈 Leadership Roles: Experience as Deputy Director and Assistant Director at Shandong Cancer Hospital highlights her leadership in clinical and research settings.

  • 👩‍🏫 Collaborative Impact: Contributions as a corresponding and co-corresponding author in multiple papers underscore her role in guiding research teams.

  • 🏆 Recognition of Excellence: Consistent publication in top-tier journals (Q1) across diverse aspects of nuclear medicine and oncology points to widespread recognition in her field.

🎓 Education

  • Ph.D. in Oncology (2018.09-2022.06) – Shandong University, under the mentorship of Jinming Yu (Academician of Chinese Academy of Engineering).
  • Master’s in Oncology (2013.09-2016.06) – Jinan University, mentored by Shuanghu Yuan.
  • Bachelor’s in Traditional Chinese and Western Medicine Clinical (2007.09-2012.06) – Shandong University of Traditional Chinese Medicine.

💼 Experience

  • 🔺 Deputy Director (2021.09-2022.08) – MDT Quality Management Office, Shandong Cancer Hospital.
  • Radiotherapy Physician (2017.07-Present) – Shandong Cancer Hospital.
  • Assistant Director (2020.12-2021.08) – Radioimmunity and Molecular Imaging Room, Shandong Cancer Hospital.

🔮 Research Interests On Oncology

Dr. Wei’s research delves into new imaging techniques for cancer detection and treatment evaluation. Her primary focus is on developing prognostic and predictive imaging biomarkers, enhancing individualized therapy planning, and monitoring cancer progression.

🏆 Awards

  • Recognition for contributions to cancer imaging and personalized therapy at Shandong Cancer Hospital.

📝 Publications

  • Title: FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer
    Authors: Wei Yuchun#, Ma Li, Li Pei, Lu Jie, Ren Jiazhong, Yan Shoumei, Wu Hongbo, Yuan Shuanghu, Fu Zheng, Yu Jinming
    Year: 2023
    Citations: Radiology, 308(2):e222785. (JCR Q1, IF=19.7)

  • Title: [18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
    Authors: Yinjun Dong#, Zhendan Wang#, Xinying Hu, Yuhong Sun, Jingjie Qin, Qiming Qin, Shuguang Liu, Shuanghu Yuan, Jinming Yu, Yuchun Wei* (Corresponding author)
    Year: 2024
    Citations: J Nucl Med. (JCR Q1, IF=9.1)

  • Title: Early Detection of Radiation-Induced Myocardial Damage by [18F]AlF-NOTA-FAPI-04 PET/CT Imaging
    Authors: Wei Yuchun#, Sun Y, Liu J, Zhang G, Qin X, Xu S, Wang S, Tao Y, Pei J, Yu J
    Year: 2023
    Citations: Eur J Nucl Med Mol Imaging, 50(2):453-464. (JCR Q1, IF=10.057)

  • Title: Response Prediction Using 18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy
    Authors: Hu X, Zhou T, Ren J, Duan J, Wu H, Liu X, Mu Z, Liu N, Wei Yuchun* (Co-corresponding author), Yuan ST*
    Year: 2023
    Citations: J Nucl Med, 64(4):625-631. (JCR Q1, IF=11.082)

  • Title: [18F]AlF‑NOTA‑FAPI‑04: FAP‑targeting Specificity, Biodistribution, and PET/CT Imaging of Various Cancers
    Authors: Wei Yuchun#, Zheng Jinsong, Ma Li, Liu Xiaoli, Xu Shengnan, Wang Shijie, Pei Jinli, Cheng Kai, Yuan Shuanghu, Yu Jinming
    Year: 2022
    Citations: Eur J Nucl Med Mol Imaging, 49(8):2761-2773. (JCR Q1, IF=10.057)

  • Title: [18F]AlF‑NOTA‑FAPI‑04 PET/CT Uptake in Metastatic Lesions on PET/CT Imaging Might Distinguish Different Pathological Types of Lung Cancer
    Authors: Wei Yuchun#, Cheng Kai#, Fu Zheng, Zheng Jinsong, Mu Zhengshuai, Zhao Chenglong, Liu Xiaoli, Wang Shijie, Yu Jinming, Yuan Shuanghu
    Year: 2022
    Citations: Eur J Nucl Med Mol Imaging, 49(5):1671-1681. (JCR Q1, IF=10.057)

  • Title: Tumor Angiogenesis at Baseline Identified by 18F-Alfatide II PET/CT May Predict Survival Among Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
    Authors: Wei Yuchun#, Qin Xueting, Liu Xiaoli, Zheng Jinsong, Luan Xiaohui, Zhou Yue, Yu Jinming, Yuan Shuanghu
    Year: 2022
    Citations: J Transl Med, 20(1):63-72. (JCR Q2, IF=8.44)

  • Title: Value of [18F]AlF‑NOTA‑FAPI‑04 PET/CT for Differential Diagnosis of Malignant and Various Inflammatory Lung Lesions: Comparison with [18F]FDG PET/CT
    Authors: Kailin Qiao, Xueting Qin, Shuai Fu, Jiazhong Ren, Jing Jia, Xinying Hu, Yuanyuan Tao, Shuanghu Yuan, Yuchun Wei (Corresponding author)
    Year: 2023
    Citations: Eur Radiol. (JCR Q1, IF=5.9)

  • Title: Stereotactic Comparison Study of 18F-Alfatide and 18F-FDG PET Imaging in an LLC Tumor-Bearing C57BL/6 Mouse
    Authors: Wei Yuchun# et al.
    Year: 2016
    Citations: Sci Rep, 6:28757. (JCR Q1, IF=5.228)

  • Title: Diagnostic Value of 18F-NOTA-FAPI PET/CT in a Rat Model of Radiation-Induced Lung Damage
    Authors: Xueting Qin, Shijie Wang, Xiaoli Liu, Jinghao Duan, Kai Cheng, Zhengshuai Mu, Jing Jia, Yuchun Wei (Co-corresponding author), Shuanghu Yuan
    Year: 2022
    Citations: Front Oncol, 12:879281. (JCR Q2, IF=5.738)

📅 Conclusion

Dr. Yuchun Wei is a leading figure in oncology and molecular imaging, dedicated to developing cutting-edge imaging techniques to revolutionize cancer diagnosis and treatment. Her contributions have significantly advanced the field of individualized cancer therapy, making her a standout candidate for this award.

Zhijian Huang | Oncology | Excellence in Research

Posted on by sciencefather

Dr. Zhijian Huang | Oncology | Excellence in Research

Fujian Cancer Hospital | China

Dr. Zhijian Huang is a distinguished Deputy Chief Physician at the Department of Breast Surgical Oncology at Fujian Medical University Cancer Hospital in Fuzhou, China. With extensive expertise in breast cancer treatment and reconstructive surgery, Dr. Huang has contributed significantly to understanding tumor metastasis mechanisms and immunological factors in breast cancer. He is currently expanding his research at Harvard University Beth Israel Deaconess Medical Center, focusing on molecular pathways and predictive models.

Professional profile👤

Google Scholar

Strengths for the Awards✨

  • Extensive Research Contributions: Dr. Huang has an impressive publication record, with 14 peer-reviewed articles, many in high-impact journals such as Frontiers in Oncology, BMC Cancer, and Biosafety and Health. His research spans crucial areas of breast cancer, including tumor metastasis mechanisms, immune microenvironments, and biomarker discovery.
  • Interdisciplinary Expertise: His skills in bioinformatics, molecular biology techniques (e.g., CRISPR/Cas9 gene editing), and clinical integration set him apart as a versatile researcher capable of bridging computational and experimental oncology.
  • Clinical Impact: Dr. Huang has contributed directly to patient care through advancements in comprehensive breast cancer treatment, breast reconstruction techniques, and real-world studies of therapeutic efficacy.
  • Recognition and Leadership: The two prestigious awards he received in 2023 for his work on artificial intelligence in breast cancer diagnostics and immune microenvironments reflect the impact and recognition of his research in the medical community.
  • International Collaboration: His postdoctoral research at Harvard University’s Beth Israel Deaconess Medical Center adds a global dimension to his work and highlights his active engagement in cutting-edge breast cancer research.

Education 🎓

Dr. Huang earned his Doctor of Medicine (M.D.) in Clinical Medicine from Southern Medical University in Guangzhou, China, in 2022. Prior to that, he completed his Master of Medicine at Fujian Medical University in 2009 and his Bachelor of Medicine at the same institution in 2005.

Experience 💼

Dr. Huang has been serving at Fujian Medical University Cancer Hospital since 2009, performing breast tumor surgeries, comprehensive treatments, and breast reconstructions. From 2016 to 2017, he trained at the Affiliated Cancer Hospital of Xiangya Medical College, focusing on advanced tumor plastic surgery techniques. In 2024, he joined Harvard University Beth Israel Deaconess Medical Center as a Postdoctoral Researcher, delving deeper into breast cancer mechanisms and therapeutic advancements.

Research Interests On Oncology🔬

His research revolves around tumor metastasis mechanisms, breast cancer immunology, and molecular biology techniques. He is skilled in Western blotting, lentiviral packaging, CRISPR/Cas9 gene editing, and developing mouse models. Dr. Huang also specializes in bioinformatics analysis, employing tools like SPSS and GraphPad Prism.

Awards 🏆

  • 2023: Third Prize, Fujian Medical Science and Technology Award for research on ultrasound-assisted artificial intelligence diagnosis of breast cancer, immune microenvironment, and metastatic molecular mechanisms.
  • 2023: Third Prize, Fujian Anti-Cancer Association Science and Technology Award for research on immune microenvironment, metastatic molecular mechanisms of breast cancer, and infusion port clinical applications.

Publications 📚

  • Title: Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
    Authors: C Xiao, L Yang, L Jin, W Lin, F Zhang, S Huang, Z Huang
    Year: 2022
    Citations: 42

  • Title: Application of oncolytic virus in tumor therapy
    Authors: Z Huang, H Guo, L Lin, S Li, Y Yang, Y Han, W Huang, J Yang
    Year: 2023
    Citations: 29

  • Title: A novel XGBoost method to infer the primary lesion of 20 solid tumor types from gene expression data
    Authors: S Chen, W Zhou, J Tu, J Li, B Wang, X Mo, G Tian, K Lv, Z Huang
    Year: 2021
    Citations: 14

  • Title: miRNA-1260b promotes breast cancer cell migration and invasion by downregulating CCDC134
    Authors: Z Huang, S Zhen, L Jin, J Chen, Y Han, W Lei, F Zhang
    Year: 2023
    Citations: 12

  • Title: A novel framework to predict breast cancer prognosis using immune-associated LncRNAs
    Authors: Z Huang, C Xiao, F Zhang, Z Zhou, L Yu, C Ye, W Huang, N Li
    Year: 2021
    Citations: 12

  • Title: HAUS5 is a potential prognostic biomarker with functional significance in breast cancer
    Authors: Z Huang, J Yang, W Qiu, J Huang, Z Chen, Y Han, C Ye
    Year: 2022
    Citations: 10

  • Title: 肝癌病人术后早期肠内与肠外营养支持治疗的比较
    Authors: 周东, 刘胜, 应敏刚, 黄峰, 吴贤毅, 黄志坚
    Year: 2012
    Citations: 10

  • Title: Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: Prognosis and influence of tumor microenvironment
    Authors: LH Yang, LZ Xu, ZJ Huang, HH Pan, M Wu, QY Wu, T Lu, YP Zhang
    Year: 2022
    Citations: 5

  • Title: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer
    Authors: W Huang, C Wang, Y Shen, Q Chen, Z Huang, J Liu, X Lin, L Wang, F Wu
    Year: 2024
    Citations: 4

  • Title: Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker
    Authors: P Chen, X Yang, P Wang, H He, Y Chen, L Yu, H Fang, F Wang, Z Huang
    Year: 2023
    Citations: 4

Conclusion 🔖

Dr. Zhijian Huang’s illustrious career is marked by a deep commitment to advancing breast cancer treatment through surgical expertise and cutting-edge research. His work continues to shape the future of cancer therapy, bridging molecular insights with clinical applications to improve patient outcomes worldwide.

Juan Ren | Oncology | Excellence in Research

Posted on by sciencefather

Prof. Dr. Juan Ren | Oncology | Excellence in Research

Professor | The First Affiliated Hospital of Xi’an Jiaotong University | China

Dr. Juan Ren, M.D., Ph.D., is a distinguished professor at the Cancer Center of the First Affiliated Hospital of Xi’an Jiaotong University. With a profound dedication to oncology research, she has made significant contributions to understanding cancer biology, particularly in ovarian and endometrial cancers. Her research has led to advancements in tumor markers, angiogenesis, and targeted therapies, establishing her as a leading figure in the field of cancer research.

Profile👤

Scopus

Strengths for the Awards✨

✅ Extensive Research Experience: Dr. Juan Ren has led multiple research projects as a Principal Investigator under prestigious grants, including the National Natural Science Foundation of China and Science & Technology Grants of Shaan’ Xi Province. These projects focus on ovarian cancer, angiogenesis, and targeted cancer therapies, demonstrating a strong track record in cutting-edge oncology research.

✅ Outstanding Publication Record: With over 30 peer-reviewed publications in high-impact journals like Cancer Research, FASEB Journal, and the Journal of Biological Chemistry, Dr. Ren has significantly contributed to the field of cancer biology, epigenetics, and targeted therapy. Publications address crucial aspects of cancer metastasis, angiogenesis, and drug resistance, which align with innovative approaches in cancer treatment.

✅ Recognized Achievements and Awards: Dr. Ren has received multiple prestigious awards, including the First and Second Awards for Excellence in Science and Technology from the Shaan’ Xi Provincial Government and the Cleveland Clinic Foundation’s Excellent Research Award. These accolades highlight a well-respected and impactful career in scientific research.

✅ International Collaboration & Impact: Having worked with institutions like the Cleveland Clinic Foundation, USA, Dr. Ren has demonstrated global research engagement, making their work influential beyond China.

✅ Innovative Contributions to Cancer Treatment: Research focusing on GPR4, VEGF receptors, phospholipase A2 inhibitors, and epigenetic interventions positions Dr. Ren as a pioneer in targeted therapies and precision medicine for cancer treatment.

Education 🎓

Dr. Ren earned her medical degree from Xi’an Medical University, where she was recognized as an outstanding student. She later pursued a Ph.D. at Xi’an Jiaotong University, focusing on cancer research. Her academic excellence was further acknowledged with prestigious awards, highlighting her dedication and contributions to medical science.

Experience 🏥

Dr. Ren has held key positions in academia and research. As a principal investigator, she has led multiple groundbreaking projects funded by the National Natural Science Foundation of China. Her research has explored the molecular mechanisms of cancer progression, metastasis, and treatment resistance. She has collaborated with international institutions, further enriching her expertise and contributions to oncology.

Research Interests On Oncology 🔬

Dr. Ren’s research focuses on:

  • The molecular mechanisms of ovarian and endometrial cancers.
  • Tumor markers for early cancer detection.
  • The role of G-protein-coupled receptors in angiogenesis.
  • Epigenetic interventions to enhance cancer treatment.
  • The development of novel targeted therapies for gynecological malignancies.

Awards 🏆

Dr. Ren has received numerous prestigious awards, including:

  • Second Award of Achievement & Excellence in Science and Technology, Shaan’Xi Province (2013).
  • First Award of Achievement & Excellence in Science and Technology, Shaan’Xi Province (2009).
  • First Award of Achievement & Excellence in Science and Technology, Anti-Cancer Association of Shaan’Xi Province (2006).
  • Excellent Research Award, Cleveland Clinic Foundation, USA (2004).
  • Multiple awards for scientific excellence from Xi’an Jiaotong University and the Education Bureau.

Publications 📄

Dr. Ren has authored numerous high-impact research articles. Some key publications include:

  • Title: MECOM Locus Classical Transcript Isoforms Affect Tumor Immune Microenvironment and Different Targets in Ovarian Cancer
    Authors: N. Lan, S. Bai, M. Chen, F. Wu, J. Ren
    Publication Year: 2024

  • Title: Predictive Role of Elevated Neutrophil-Lymphocyte Ratio for Bone Metastasis in Esophageal Cancer
    Authors: X. Wang, Y. Gao, J. Wang, F. Wu, J. Ren
    Publication Year: 2024

  • Title: Construction of lncRNA-m6A Gene-mRNA Regulatory Network to Identify m6A-Related lncRNAs Associated with the Progression of Lung Adenocarcinoma
    Authors: J. Zhang, S. Bai, Y. Yan, X. Wang, J. Ren
    Publication Year: 2023

  • Title: Perspective of Radiotherapy for Ovarian Metastasis from Small Cell Lung Cancer
    Authors: Z. Feng, Y. Qu, X. Sun, X. Zhang, Y. Yang
    Publication Year: 2023

  • Title: Construction of Prognostic Model of Ovarian Cancer Patients Based on Immune-Related Genes
    Authors: H. Kang, S. Bai, R. Li, J. Zhang, J. Ren
    Publication Year: 2023

  • Title: Clinical Association Between Coagulation Indicators and Bone Metastasis in Patients with Gastric Cancer
    Authors: X. Wang, M. Chen, J. Ren, X. Zhang
    Publication Year: 2023

Conclusion 🔍

Dr. Juan Ren’s dedication to oncology research has significantly advanced the understanding of cancer biology. Her contributions in tumor marker identification, molecular targeting, and cancer therapy have shaped modern oncology. Through her research, leadership, and clinical expertise, she continues to inspire and drive innovation in cancer treatment, making a lasting impact on the medical community worldwide.